Effect of Safinamide on Parkinson's Disease Related Chronic Pain

Summary

Primary objective: • To evaluate the potential efficacy of safinamide 100 mg once daily (OD), compared with placebo, as add-on therapy for PD-related chronic pain Secondary objectives: * Percentage of pain responders * Clinical Global Impression for pain * Patient Global Impression for pain * Reduction in use of pain drugs * Mood * Motor and non-motor symptoms Safety Objectives: • Safety and tolerability

Timeline

Start

2019-04-09

Primary completion

2021-04-30

Completion

2021-05-03

Drugs

Indications